Showing 301-310 of 326 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Transcriptional memory in human islet organogenesis | Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) | Eiji Yoshihara | Cures | 01-April-2022 to 31-March-2027 | $749.995,50 |
| Clinic-based sleep screening and intervention to improve sleep health in adolescents with type 1 diabetes | Regents of the University of Colorado | Erin Cobry | Transportfolio | 01-April-2022 to 31-March-2027 | $750.000,00 |
| A smart Semiconductor based Continuous Diabetes Monitoring Platform | Integrated Medical Sensors Inc | Muhammad Mujeeb-U-Rahman | Improving Lives | 01-June-2022 to 07-November-2025 | $500.000,00 |
| The Development of 3-β-hydroxybutyrate binding protein based electrochemical micro-sensor and its application for CKM system | The University of North Carolina at Chapel Hill | Koji Sode | Improving Lives | 01-October-2022 to 30-September-2026 | $799.999,96 |
| Microneedle Sensor for Simultaneous Continuous Monitoring of Ketone and Glucose | University of California, San Diego | Joseph Wang | Improving Lives | 01-October-2022 to 30-April-2026 | $799.998,91 |
| Development of Uni-molecular Glucose-responsive Insulin | Stanford University | Danny Hung-Chieh Chou | Improving Lives | 01-April-2022 to 31-March-2026 | $749.998,34 |
| Prevascularized encapsulation platform with local immunosuppression for Islet transplantation | The Methodist Hospital Research Institute | Alessandro Grattoni | Cures | 01-August-2021 to 31-January-2026 | $660.000,00 |
| Telemedicine-Delivered Cognitive Behavioral Therapy to Reduce Diabetes Distress in Young Adults with Type 1 Diabetes (CBT-DD) | Albert Einstein College of Medicine | Jeffrey Gonzalez | Improving Lives | 01-September-2021 to 30-June-2027 | $1.870.600,00 |
| Advanced Oxygen Generator for Oxygenated Cell Capsules | Giner, Inc. | Linda Tempelman | Cures | 01-June-2021 to 30-September-2026 | $448.173,29 |
| Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening | Jaeb Center for Health Research | Adam Glassman | Improving Lives | 01-February-2021 to 31-August-2026 | $750.000,00 |